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he Effects of Diet on Inflammation
mphasis on the Metabolic Syndrome
ario Giugliano, MD, PHD,* Antonio Ceriello, MD,† Katherine Esposito, MD, PHD*
aples, Italy; and Coventry, United Kingdom
Reducing the incidence of coronary heart disease with diet is possible. The main dietary
strategies include adequate omega-3 fatty acids intake, reduction of saturated and trans-fats,
and consumption of a diet high in fruits, vegetables, nuts, and whole grains and low in refined
grains. Each of these strategies may be associated with lower generation of inflammation.
This review examines the epidemiologic and clinical evidence concerning diet and inflam-
mation. Dietary patterns high in refined starches, sugar, and saturated and trans-fatty acids,
poor in natural antioxidants and fiber from fruits, vegetables, and whole grains, and poor in
omega-3 fatty acids may cause an activation of the innate immune system, most likely by an
excessive production of proinflammatory cytokines associated with a reduced production of
anti-inflammatory cytokines. The whole diet approach seems particularly promising to reduce
the inflammation associated with the metabolic syndrome. The choice of healthy sources of
carbohydrate, fat, and protein, associated with regular physical activity and avoidance of
smoking, is critical to fighting the war against chronic disease. Western dietary patterns warm
up inflammation, while prudent dietary patterns cool it down. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.052677–85) © 2006 by the American College of Cardiology Foundation
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Clow-fat diet (30% of total calories) is still considered by
any physicians to be a healthy choice for both primary and
econdary prevention of cardiovascular disease (CVD) (1).
n unintended consequence of emphasizing low-fat diets
ay have been to promote unrestricted carbohydrate intake,
hich reduces high-density lipoprotein cholesterol (HDL-C)
nd raises triglyceride levels, exacerbating the metabolic
anifestations of the insulin resistance syndrome, also
nown as the metabolic syndrome (2,3).
Three dietary strategies may help prevent coronary heart
isease (CHD) (4): 1) increase consumption of omega-3
atty acids from fish or plant sources; 2) substitute nonhy-
rogenated unsaturated fats for saturated and trans-fats; and
) consume a diet high in fruits, vegetables, nuts, and whole
rains and low in refined grains (Fig. 1). The effects of diet
n CHD can be mediated through multiple biologic path-
ays other than serum lipids, including oxidative stress,
ubclinical inflammation, endothelial dysfunction, insulin
ensitivity, blood pressure, and thrombotic tendency (5).
Current evidence supports a central role for inflammation
n all phases of the atherosclerotic process (6). Circulating
arkers of inflammation, such as C-reactive protein (CRP),
umor necrosis factor (TNF)-alpha, and some interleukins
IL-6, IL-18), correlate with propensity to develop ischemic
vents (7–9); moreover, circulating phase reactants elicited
y inflammation may not only mark increased risk for
ascular events but in some cases may also contribute to
heir pathogenesis (10). Increasing attention has also been
From the *Division of Metabolic Diseases, Center of Excellence for Cardiovascular
iseases, University of Naples SUN, Italy; and †Warwick Medical School, Coventry,
nited Kingdom.d
Manuscript received December 17, 2005; revised manuscript received February 27,
006, accepted March 16, 2006.aid to the direct vascular effects of plasma proteins that
riginate from adipose tissue, especially adiponectin, which
xhibits potent anti-inflammatory and antiatherosclerotic
ffects (11). Low plasma adiponectin levels are an indepen-
ent risk factor for future development of type 2 diabetes
12), whereas high plasma adiponectin concentrations are
ssociated with a lower risk of myocardial infarction in men
13). Moreover, it has become increasingly clear that in-
ammation strictly correlates with endothelial dysfunction
nd insulin resistance, with the best evidence coming from
atients with the metabolic syndrome (14).
We put forward the hypothesis that each dietary strategy
ssociated with a lower CHD risk may in fact be associated
ith lower generation of a proinflammatory milieu, which
ay be one important mechanism linking healthy diets to
educed CHD risk. Criteria used for study selection to be
ncluded in the current review were English language,
elevance to clinicians, study design, and venue of publica-
ion. Because controlled trials with clinical end points and
ssessment of inflammatory markers were lacking, we gave
eight to observational studies and dietary interventional
rials reporting intermediate end points.
NCREASE CONSUMPTION OF OMEGA-3 FATTY ACIDS
he benefits of omega-3 fatty acids in decreasing the risk of
udden cardiac death have been demonstrated in animal,
pidemiologic, metabolic, and small clinical trials (15).
hese compounds have long been recognized to have
nti-inflammatory activity, and their use in consolidated
nflammatory diseases, such as rheumatoid arthritis and
rohn’s disease, is expanding (16). Omega-3 fatty acids
ecrease the arachidonic acid content of cell membranes,
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Diet and Inflammation August 15, 2006:677–85esulting in the synthesis of eicosanoids that have fewer
nflammatory properties than those derived from omega-6
atty acids. Although omega-3 fatty acids may inhibit the
ynthesis of proinflammatory cytokines, such as TNF-alpha,
L-1, and IL-2 (17) and decrease expression of adhesion
olecules on the endothelium (18), the results of ex vivo
uman studies investigating the effect of omega-3 fat intake
n inflammatory markers are not conclusive but may have
een influenced by the specificity of cells investigated and
ssay procedures (19).
bservational studies. In 405 healthy men and 454
ealthy women, intake of omega-3 fatty acids eicosapenta-
noic acid (EPA) and docosaexaenoic acid (DHA) was
nversely associated with plasma levels of markers of TNF-
lpha activity, such as soluble TNF receptors 1 and 2;
oreover, high intake of both omega-3 and omega-6 fatty
cids was associated with the lowest level of inflammation
20). Therefore, the combination of omega-3 and omega-6
atty acids may work well on CHD risk, as demonstrated by
ther cross-sectional data indicating that the combined
ntake of both fatty acids is associated with a lower risk of
HD than either type of fatty acid alone (21). Another
ross-sectional study (22) of 727 women from the Nurses’
ealth Study I cohort demonstrated lower concentrations
f many markers of inflammation and endothelial activa-
ion, including CRP, IL-6, and E-selectin, among those in
he highest quintile of omega-3 fatty acids compared with
hose in the lowest quintile. In a randomly sampled cohort
f 470 healthy middle-aged women and men from the Los
ngeles Atherosclerosis Study (23), increased dietary intake
f omega-3 fatty acids was associated with a blunted effect
f the variant 5-lipoxygenase genotype (lacking the com-
on allele) to increase carotid artery intima-media thickness
nd circulating CRP levels. In the ATTICA study, those
Abbreviations and Acronyms
ALA  alpha-linolenic acid
CHD  coronary heart disease
CRP  C-reactive protein
CVD  cardiovascular disease
IL  interleukin
sICAM  soluble intercellular adhesion molecule
sVCAM  soluble vascular cell adhesion molecule
TNF  tumor necrosis factorFigure 1. Some mechanisms through which unhealthy dietary patterns may lho consumed at least 300 g of fish per week had 33% lower
RP compared with non-fish consumers (24). Lastly, in
ubjects with existing CHD, granulocyte DHA content was
nversely associated with CRP levels (25).
nterventional studies. Changing the proportion of omega-3
atty acids of the diet may influence circulating markers of
nflammation and endothelial activation in hypercholester-
lemic subjects fed 2 diets low in saturated fat and high in
olyunsaturated fats (PUFA), as compared with an average
merican diet (26). The alpha-linolenic acid (ALA) diet
6.5% of energy from ALA) decreased CRP, vascular cell
dhesion molecule-1, and E-selectin more than the linoleic
cid (LA) diet (12.6% energy from LA). In another study,
ietary supplementation with ALA (15 ml linseed oil per
ay) for 3 months in 50 dyslipidemic subjects significantly
ecreased CRP (38% compared with baseline values), serum
myloid A (23%), and IL-6 (10%) levels independent of
ipid changes (27). Consumption of an ALA-enriched
argarine was also associated with lowering of CRP levels
n hypercholesterolemic subjects (28). However, most of the
tudies using fish oil or pure omega-3 fatty acids supple-
entation have failed to show any effect on CRP levels
29–33), unless the fish oil supplement was given at a high
ose (14 g/day) (34).
Although some epidemiologic studies have shown an
nverse correlation between dietary intake of fish or fish oil
nd circulating markers of inflammation, clinical trials have
ot yet confirmed these effects. On the other hand, ALA
ppears to have anti-inflammatory potential, and future
tudies should focus on this.
UBSTITUTE NONHYDROGENATED UNSATURATED
ATS FOR SATURATED AND TRANS-FATS
educing trans-fat. Higher intake of trans-fats or, to a
esser extent, saturated fats has been shown to be associated
ith increased CHD risk among 80,082 women in the
urses’ Health Study cohort, whereas higher intakes of
olyunsaturated (nonhydrogenated) and monounsaturated
ats were associated with decreased risk (35). It is not
ntirely clear, however, whether the effects of this substitu-
ion are primarily due to introducing beneficial effects of
nsaturated fats, moving away from the detrimental effects
f saturated and trans-fats, or both. Moreover, the relation
ith CHD risk is explained only partially by the adverseead to coronary heart disease (CHD). LDL  low-density lipoprotein.
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August 15, 2006:677–85 Diet and Inflammationffect of trans-fatty acids on the lipid profile (36), because
he positive relation between trans-fats and cardiovascular
isk is greater than one would predict based solely on its
dverse effects on lipids.
BSERVATIONAL STUDIES. In a cross-sectional study of 730
omen from the Nurses’ Health Study I cohort, CRP levels
ere 73% higher among those in the highest quintile of
rans-fat intake, compared with the lowest quintile (37).
arkers of endothelial activation such as E-selectin, soluble
ntercellular adhesion molecule (sICAM)-1, and soluble
ascular cell adhesion molecule (sVCAM)-1 were also
igher, suggesting that a higher intake of trans-fatty acids
ould favor inflammation and adversely affect endothelial
unction. Moreover, a previous paper from the same patient
ohort showed that trans-fat intake was positively associated
ith IL-6 and CRP only in women with higher body mass
ndex (38). A long-term vegetarian diet, which is low in
aturated and trans-fats, is associated with better antioxi-
ant status and CHD risk profile, and reduced concentra-
ion of CRP as compared to the diet of apparently healthy
mnivores (39).
NTERVENTIONAL STUDIES. Baer et al. (40) have provided
vidence that dietary fatty acids can modulate markers of
nflammation in healthy humans fed controlled diets. In
articular, CRP and E-selectin concentrations were higher
fter consumption of a trans-fatty acids diet than after
onsumption of a carbohydrate diet, although IL-6 concen-
rations were lower after consumption of an oleic acid diet
han after consumption of trans- and saturated fatty acids.
owever, another study did not find any difference of
ietary fat type on CRP levels (41).
educing saturated fats and cholesterol. OBSERVATIONAL
TUDIES. A positive correlation between consump tion of
aturated fats and plasma biomarkers of inflammation has
een found (42,43).
NTERVENTIONAL STUDIES. Cholesterol feeding increases
RP levels in healthy subjects but not in obese insulin-
esistant patients whose CRP levels were already elevated at
aseline (44). In 35 patients with primary hypercholester-
lemia, an 8-week low-cholesterol/low-saturated fat diet
30% total fat, 5% saturated fat, cholesterol 200 mg/day)
as associated with significant reduction of large artery
tiffness (from 8.9  2.0 m/s to 8.1  1.9 m/s, 11%) which
orrelated with reduction of plasma CRP levels (r  0.59)
45). One problem with this kind of intervention study is
he confounding effect of weight loss that by itself may
educe inflammation and improve endothelial function (46).
oreover, energy-restricted low-fat and low-carbohydrate
iets both significantly decreased several biomarkers of
nflammation, such as CRP, TNF-alpha, IL-6, and
CAM-1, leading to suggest that, in the short-term, weight
oss may be the driving force underlying the reductions in
ost of the inflammatory biomarkers (47). sONSUME A DIET HIGH IN FRUITS,
EGETABLES, NUTS, AND WHOLE GRAINS AND
OW IN REFINED GRAINS, FRUITS, AND VEGETABLES
n inverse association between fruit and vegetable con-
umption and CVD has repeatedly been reported (4,48).
owever, only few studies have related fruit and vegetable
onsumption to inflammatory status.
bservational studies. Data from the Massachusetts His-
anic Elders Study (49) obtained from 445 Hispanic and
54 non-Hispanic white elders showed that greater fre-
uency of fruit and vegetable intake was associated with
ower CRP and homocysteine concentrations. With each
dditional serving of fruit and vegetable intake, the risk of
aving high CRP (10 mg/l) and homocysteine concen-
rations decreased by 21% and 17%, respectively. Unfortu-
ately, the study used a nonsensitive assay for CRP, limiting
he ability to extend the association at the lower end of CRP
istribution.
The antioxidant components of fruit and vegetables,
ncluding vitamins and flavonoids, are supposed to contrib-
te to their anti-inflammatory effect (50). Observational
tudies have shown an inverse association between dietary
otal antioxidant capacity, serum carotenoids and vitamins,
nd markers of inflammation (51,52). The intake of dietary
ber may play a role as well. Using data from the National
ealth and Nutrition Examination Survey 1999 to 2000,
jani et al. (53) examined the relation between dietary fiber
nd CRP in 3,920 participants. Dietary fiber intake was
nversely associated with serum CRP concentrations: The
djusted odds ratio for increased CRP levels (3 mg/l) was
.59 (p  0.006) for the highest quintile of fiber intake
ompared with the lowest. The results were not affected
fter exclusion of persons with diabetes, cancer, CVD, or
RP levels 10 mg/l. The results of Ajani et al. (53)
onfirmed the previous findings of King et al. (43).
nterventional studies. Drinking 500 ml/day of high-
ressurized orange juice for 14 days reduced plasma CRP by
0% and 56% in men and women, respectively (54). A
andomized controlled 4-week trial in nonsmoking men
howed that subjects assigned to high consumption (8
ervings/day) of carotenoid-rich vegetables and fruit had
ignificantly reduced CRP levels compared with those who
onsumed 2 servings/day (55). In contrast, another random-
zed controlled parallel 6-week dietary intervention trial in
ealthy volunteers failed to show any effect of diets differing
arkedly in the amounts of vegetables, berries, and apple on
RP levels (56). On the other hand, the addition of
ntioxidant supplements (57) or vegetables to the diet (58)
as been shown to reverse the increase in circulating
dhesion molecules (sICAM-1 and sVCAM-1), proinflam-
atory cytokines (IL-6 and TNF-alpha), and endothelial
ysfunction induced by a single high-fat (saturated) meal
onsumption. More work is needed to characterize fruits
nd vegetables with anti-inflammatory effects and the sub-
tances responsible.
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n inverse association between nut consumption and CHD
isk has been consistently found (4). Nuts are rich in
onounsaturated and polyunsaturated fatty acids, which
akes them a palatable choice of healthy fats. Monounsat-
rated fats may contribute to decreased CHD risk by
melioration of lipid profile (59), by reducing postprandial
riglyceride concentrations (60), and by decreasing soluble
nflammatory adhesion molecules in patients with hyper-
holesterolemia (61). Moreover, the relatively high arginine
ontent of nuts has been suggested as one of the potential
iologic mechanisms for their cardioprotective effect, be-
ause consumption of arginine-rich foods is associated with
ower CRP levels (62).
EDUCE REFINED GRAINS
arbohydrate type affects CHD risk. Refined carbohydrates
re highly processed, resulting in removal of fiber, vitamins,
inerals, phytonutrients, and essential fatty acids. High
ntake of refined starches and sugars causes rapid swings in
lood glucose and insulin levels, may increase hunger, and
ay elevate free fatty acid levels (63). Acute hyperglycemia
n normal humans impairs endothelium-dependent vasodi-
ation (64) and reduces nitric oxide availability (65). By its
ass action, postprandial hyperglycemia leads to increased
issue glucose uptake and metabolism by ordinarily minor
athways (Fig. 2). One major consequence of this activation
s unrestrained production of free radicals which may
romote atherogenesis by different mechanisms (66,67).
trictly related to this is the emerging evidence that CHD
ay be more strongly related to post-load glucose hyper-
lycemia than to fasting hyperglycemia (68). Although the
echanisms underlying these associations are not fully clear,
ecent data indicate that short-term acute hyperglycemia
ay increase circulating levels of free radicals and proin-
ammatory cytokines, such as IL-6, IL-18, and TNF-alpha
69), providing a plausible explanation for the deleterious
ffects of rapid glycemic waves on vasculature.
bservational studies. Festa et al. (70) evaluated the
elationship of CRP with fasting and post-challenge plasma
lucose in nondiabetic subjects from the Insulin Resistance
therosclerotic Study: after adjustment for many demo-
raphic and anthropometric variables, a significant associa-
ion was found for 2 h glucose only with CRP levels.
oreover, a cross-sectional analysis conducted in 780 dia-
etic men from the Health Professionals’ Follow-Up Study
71) has recently shown that diets low in glycemic load and
igh in fiber may increase plasma adiponectin concentra-
ions in diabetic patients.
nterventional studies. Meal modulation of circulating
nflammatory and anti-inflammatory cytokines may play a
ole in the detrimental or beneficial effects of different types
f carbohydrates. For example, the fiber content of a
igh-carbohydrate meal may influence plasma levels of
diponectin and IL-18: the higher the quantity of fiber in Che load, the greater the inhibition of plasma IL-18 and
timulation of adiponectin (72). On the other hand, in
verweight subjects a high consumption of sugar-sweetened
oods and drinks increased haptoglobin and transferrin but
ad, at best, only a limited influence on CRP (73).
LCOHOL
lcohol, mostly wine, represents an important component
f the Mediterranean diet; moreover, moderate alcohol
ntake has consistently been shown to be associated with a
ower risk for fatal and nonfatal cardiovascular disease (74).
bservational studies. Lower concentrations of several
arkers of inflammation, including CRP, have been re-
orted among moderate consumers of alcohol in individuals
ith and without pre-existing CVD (75–77). The associa-
ion has recently been confirmed in large prospective stud-
es, in both Europe (78) and the U.S. (79), suggesting that
thanol itself might be largely responsible for the potential
nti-inflammatory effects of beer, wine, or liquor.
nterventional studies. Sierksma et al. (80) demonstrated
significant reduction of CRP concentrations and fibrino-
en after 3 weeks of diet-controlled consumption of 4 (men)
r 3 (women) glasses of beer. Moreover, a 4-week consump-
ion of 30 g/day of red wine led to a significant decrease in
igure 2. Mechanisms through which hyperglycemia may generate inflam-
atory responses. NF-kB  nuclear factor kappa B; PKC  protein
inase C.RP (21%) in healthy adult men (81).
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August 15, 2006:677–85 Diet and InflammationHE WHOLE DIET APPROACH
he role of overall dietary patterns in predicting long-term
isk of CHD has recently been demonstrated (82). In
ractical terms, a prudent dietary pattern is characterized by
he choice of foods that satisfy all the strategies so far
iscussed for reducing CHD risk, that is, a higher intake of
ruits, vegetables, legumes, whole grains, poultry, and fish.
eedless to say, this pattern is associated with lower risk of
HD, as opposed to a Western dietary pattern (higher
ntakes of red and processed meat, sweets and desserts,
otatoes and French fries, and refined grains) which is
ssociated with an increased risk. As modern eating patterns
f Western societies generate an almost endless postprandial
hase through the day, a chronic activation of the innate
mmune system could exist during most parts of the day.
bservational studies. In a cross-sectional study of 732
omen from the Nurses’ Health Study I cohort (83), a
rudent pattern was inversely associated with plasma con-
entrations of CRP and E-selectin, whereas the Western
attern showed a positive relation with CRP, E-selectin,
ICAM-1, and sVCAM-1 after adjustment for all con-
ounders. A positive correlation between the Western pat-
ern and higher plasma CRP levels has also been found in
en (42). Moreover, a Western-type dietary pattern that
ncreases chronic inflammation raises the risk of developing
ype 2 diabetes (84). In contrast, another observational study
ound that CRP levels were only marginally associated with
ietary and lifestyle factors in 760 subjects of both genders
85).
nterventional studies. Jenkins et al. (86) found a reduc-
ion of CRP levels (28% vs. baseline) in hyperlipidemic
atients following a whole diet approach, which was com-
arable to statin therapy (33% reduction of CRP levels) and
ndependent of changes in body weight. The diet, which
as low in saturated fat and included viscous fibers, al-
onds, soy protein, and plant sterols, also induced reduc-
ion in lipids that was comparable to lovastatin therapy.
Although the whole diet approach cannot allow deter-
ining whether the benefit is due to an added nutrient, a
emoved nutrient, or a combination of both, the evidence
uggests that numerous dietary changes contribute to the
eduction in chronic disease risk.
HE MEDITERRANEAN DIET
he Mediterranean-style diet can be considered a good
xample of a prudent dietary pattern.
bservational studies. In a large prospective survey in-
olving about 22,000 adults from Greece (the Greek cohort
f the EPIC [European Prospective Investigation into
ancer and Nutrition] study), an inverse correlation be-
ween a greater adherence to a Mediterranean-style diet and
eath has been shown (87). In particular, approximately a
/9 increment in the Mediterranean diet score was associ-
ted with a 25% reduction in total mortality and a 33%
eduction in CHD mortality. Chrysohoou et al. (88) eval- nated 1,514 men and 1,528 women from the ATTICA
tudy in Greece and observed that greater adherence to a
editerranean-style diet was associated with 20% lower
RP and 17% lower IL-6 compared with those in the
owest tertile of adherence, after various adjustments were
ade. In the Nurses’ Health Study, a Mediterranean diet
ndex score was associated with lower concentrations of
iomarkers of inflammation and endothelial dysfunction
89).
nterventional studies. The only 2 randomized trials that
ested the whole-diet approach in secondary prevention of
HD with hard clinical end points were conducted using
editerranean-style diets. In the Lyon Diet Heart Study
90), the most frequent nonfatal events were new acute
yocardial infarction and episodes of unstable angina that
re commonly due to rupture of an atherosclerotic plaque.
he risk of these 2 end points was reduced by about 70% by
he Mediterranean diet, leading to the hypothesis that
iologic changes associated with it resulted in a significant
ocal anti-inflammatory effect. Singh et al. (91) tested an
Indo-Mediterranean diet” in 1,000 patients in India with
xisting coronary disease or at high risk for coronary disease.
ompared with the control diet, the intervention diet—
haracterized by increased intake of mustard or soybean oil,
uts, vegetables, fruits, and whole grains—reduced the rate
f fatal myocardial infarction by one-third and the rate of
udden death from cardiac causes by two-thirds. Because an
expression of concern” (92) has recently been issued about
his last paper, the Lyon Heart Study remains the only
andomized trial that tested the whole diet approach with a
editerranean-style diet.
It must be pointed out that much confusion still exists
bout the meaning of the Mediterranean diet: a recent
eview (1) included the DART (Diet And Reinfarction
rial) study (93) and the GISSI (Gruppo Italiano per lo
tudio della Sopravvivenza nell’Infarto miocardico acuto)-
revenzione study (94) among the controlled trials using a
editerranean-style diet approach. Obviously, the DART
tudy tested the effect of fish intake, whereas omega-3
upplements were used in the GISSI-Prevenzione.
HE METABOLIC SYNDROME: A NEW
ARGET FOR THE WHOLE DIET APPROACH
he metabolic syndrome represents a cluster of several risk
actors for atherosclerosis, including visceral obesity, athero-
enic dyslipidemia, hyperglycemia, and hypertension, and is
trictly associated with subclinical inflammation (14,95).
ecause the metabolic syndrome is highly prevalent in the
.S. (96) and is a risk factor for CHD (14,95), interventions
imed at reducing its prevalence hopefully will contribute to
ecreasing the burden of accompanying disease.
bservational studies. Williams et al. (97) showed that
ietary patterns close to the Mediterranean diet, rich in fruit
nd vegetables and high in monounsaturated fats, were
egatively associated with features of the metabolic syn-
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Diet and Inflammation August 15, 2006:677–85rome. More recently, a reduced prevalence of the meta-
olic syndrome (38% lower) was observed among subjects of
he Framingham Offspring Study consuming the highest
ntake of cereal fiber, compared those with the lowest intake
98). In the ATTICA study (99), adherence to a
editerranean-style dietary pattern was associated with a 20%
ower risk of having the metabolic syndrome.
nterventional studies. Esposito et al. (100) explored pos-
ible mechanisms underlying a dietary intervention and
andomized 180 patients (99 men, 81 women) with the
etabolic syndrome to a Mediterranean-style diet (instruc-
ions about increasing daily consumption of whole grains,
egetables, fruits, nuts, and olive oil) versus a cardiac-
rudent diet with fat intake less than 30%. After 2 years,
ody weight decreased more in the intervention group than
n the control group, but even after controlling for weight
oss, inflammatory markers, such as IL-6, IL-7, IL-18, and
RP, and insulin resistance declined more in the interven-
ion than in the control group, and endothelial function
mproved. Only 40 patients in the intervention group still
ad metabolic syndrome after 2 years compared with 78
atients on the control diet; thus, the prevalence of the
etabolic syndrome was reduced approximately by one-half
Fig. 3). Because a similar decrease in the prevalence of the
etabolic syndrome has been obtained with rimonabant, a
annabinoid receptor blocker, in a group of obese patients
fter 1 year of treatment, with a 30% rate of discontinuation
or side effects (101,102), the whole diet approach seems
articularly intriguing and promising to reduce the cardio-
ascular burden associated with the metabolic syndrome.
It should be pointed out that a recent controlled trial
nvestigating the effect of a Mediterranean diet in 101
atients with established and treated CHD failed to show
igure 3. Effects of a 2-year dietetic approach with a Mediterranean-style
iet in patients with the metabolic syndrome. The number of componentst
f the syndrome was reduced approximately by one-half in the intervention
roup (100).ny effect on markers of inflammation, including high-
ensitivity CRP, after 1 year (103).
ONCLUSIONS
ietary patterns high in refined starches, sugar, and satu-
ated and trans-fatty acids and poor in natural antioxidants
nd fiber from fruits, vegetables, and whole grains may cause
n activation of the innate immune system, most likely by an
xcessive production of proinflammatory cytokines associ-
ted with a reduced production of anti-inflammatory cyto-
ines. This imbalance may favor the generation of a proin-
ammatory milieu, which in turn produces endothelial
ysfunction at the vascular level, and ultimately predisposes
usceptible people to increased incidence of the metabolic
yndrome and CHD. All the dietary strategies hitherto
emonstrated to reduce CHD risk are associated with
educed inflammation, which may explain, at least in part,
heir benefit at the vascular level (Fig. 4). An inflammatory
tate may also prevent a favorable responsiveness of serum
ipids to a reduced-fat low-cholesterol diet (104); if con-
rmed, these findings might generate the gloomy perspec-
ive in which the inflammatory state triggered by “Western”
ietary patterns may in turn impair the lipid-lowering effect
f low-fat diets.
Low consumption of fruit and vegetables, together with
hysical inactivity, are now among the top 10 causes of
ortality in developed countries (105). Because cardiovas-
ular diseases, various forms of cancer, and diabetes combine
igure 4. Healthy dietary patterns contribute to a lower generation of a
roinflammatory milieu, which in turn may decrease the incidence of
etabolic syndrome, type 2 diabetes, and coronary heart disease (CHD).
RP  C-reactive protein; IL  interleukin; TNF  tumor necrosis
actor.o make up nearly 70% of all deaths in the U.S. (106), and
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August 15, 2006:677–85 Diet and Inflammationhe mounting epidemic of obesity (107,108) and the meta-
olic syndrome (88) is likely to increase the prevalence of
ost of these diseases in the near future, adoption of a
ealthy lifestyle is paramount to reducing chronic disease
isk. Therefore, the choice of healthy sources of carbohy-
rates, fat, and proteins, associated with regular physical
ctivity and avoidance of smoking, is critical to fighting the
ar against chronic disease. This seems particularly important
or individuals who carry additional risk factors, such as type 2
iabetes mellitus, obesity, and the metabolic syndrome, and
ail, as most do, to have a consistent and long-term weight loss.
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